Evidence map›Paper›PMID 26823077›Full record

ArticleBMC public health2016

Why increasing availability of ART is not enough: a rapid, community-based study on how HIV-related stigma impacts engagement to care in rural South Africa.

Sarah Treves-Kagan, Wayne T Steward, Lebogang Ntswane, Robin Haller, Jennifer M Gilvydis, Harnik Gulati, Scott Barnhart, Sheri A Lippman

Abstract read
In one paragraph

Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah Treves-KaganUniversity of California, San Francisco, Center for AIDS Prevention Studies, San Francisco, CA, USA. kagan.sarah@gmail.com.
Wayne T StewardUniversity of California, San Francisco, Center for AIDS Prevention Studies, San Francisco, CA, USA. wayne.steward@ucsf.edu.
Lebogang NtswaneUniversity of Washington, International Training and Education Center for Health (ITECH) - South Africa, Pretoria, South Africa. lntswane@itech-southafrica.org.
Robin HallerUniversity of California, San Francisco, Global Health Sciences, San Francisco, CA, USA. robinhaller07@gmail.com.
Jennifer M GilvydisUniversity of Washington, International Training and Education Center for Health (ITECH) - South Africa, Pretoria, South Africa. jay@globalactionconsulting.com.
Harnik GulatiUniversity of Washington, International Training and Education Center for Health, Seattle, WA, USA. harnikg@uw.edu.
Scott BarnhartUniversity of Washington, International Training and Education Center for Health, Seattle, WA, USA. sbht@uw.edu.
Sheri A LippmanUniversity of California, San Francisco, Center for AIDS Prevention Studies, San Francisco, CA, USA. sheri.lippman@ucsf.edu.

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
CGH CDC HHS U2G GH000324NIMH NIH HHS P30 MH062246PEPFARPHS HHS 5U2GGH000324-02
6 · The paper itself

Abstract

backgroundStigma is a known barrier to HIV testing and care. Because access to antiretroviral therapy reduces overt illness and mortality, some scholars theorized that HIV-related stigma would decrease as treatment availability increased. However, the association between ART accessibility and stigma has not been as straightforward as originally predicted.

methodsWe conducted a "situational analysis"--a rapid, community-based qualitative assessment to inform a combination HIV prevention program in high prevalence communities. In the context of this community-based research, we conducted semi-structured interviews and focus groups with 684 individuals in four low-resource sub-districts in North West Province, South Africa. In addition to using this data to inform programming, we examined the impact of stigma on the uptake of services.

resultsFindings suggested that anticipated stigma remains a barrier to care. Although participants reported less enacted stigma, or hostility toward people living with HIV, they also felt that HIV remains synonymous with promiscuity and infidelity. Participants described community members taking steps to avoid being identified as HIV-positive, including avoiding healthcare facilities entirely, using traditional healers, or paying for private doctors. Such behaviors led to delays in testing and accessing care, and problems adhering to medications, especially for men and youth with no other health condition that could plausibly account for their utilization of medical services.

conclusionsWe conclude that providing access to ART alone will not end HIV-related stigma. Instead, individuals will remain hesitant to seek care as long as they fear that doing so will lead to prejudice and discrimination. It is critical to combat this trend by increasing cultural acceptance of being seropositive, integrating HIV care into general primary care and normalizing men and youths' accessing health care.

Indexed as

AdultAnti-Retroviral AgentsCommunity Health ServicesDelivery of Health CareFocus GroupsHIV InfectionsHumansMalePrejudiceRural PopulationSocial PerceptionSocial StigmaSouth AfricaAnti-Retroviral Agents

Identifiers

PMID26823077
PMCPMC4730651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.